Lunai Bioworks (LNAI) Total Current Liabilities (2011 - 2026)

Lunai Bioworks' Total Current Liabilities history runs 16 years deep, the most recent figure standing at $19.3 million for Q1 2026.

• In Q1 2026, Total Current Liabilities fell 33.14% year-over-year to $19.3 million; the TTM figure through Mar 2026 stood at $19.3 million (down 33.14% YoY), while the FY2025 annual figure was $29.2 million, down 3.81% from the prior year.
• Total Current Liabilities was $19.3 million for Q1 2026 at Lunai Bioworks, down from $20.0 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $30.3 million in Q2 2024 to a low of $6.5 million in Q2 2022.
• Historically, Total Current Liabilities has averaged $17.6 million across 5 years, with a median of $19.3 million in 2026.
• The sharpest annual moves came in 2022 and 2026: Total Current Liabilities surged 491.4% in 2022, then sank 33.14% in 2026.
• A 5-year view of Total Current Liabilities shows it stood at $11.3 million in 2022, then gained by 21.84% to $13.8 million in 2023, then surged by 107.92% to $28.6 million in 2024, then tumbled by 30.08% to $20.0 million in 2025, then slipped by 3.59% to $19.3 million in 2026.
• The last three Total Current Liabilities figures came in at $19.3 million (Q1 2026), $20.0 million (Q4 2025), and $19.7 million (Q3 2025), per Business Quant data.